\nCompania american\u0103 Johnson & Johnson (J&J) a anun\u0163at, joi, c\u0103 va cump\u0103ra firma elve\u0163ian\u0103 de biotehnologie Actelion pentru 30 de miliarde de dolari, potrivit site-ului agen\u0163iei de pres\u0103 Reuters.<\/p>\n
\nAchizi\u0163ia \u00eei va permite companiei J&J acces la portofoliul de medicamentele pentru boli rare al grupului elve\u0163ian, ceea ce va diversifica oferta de medicamente a firmei americane, \u00een contextul \u00een care cel mai important produs, Remicade (pentru artrit\u0103), se confrunt\u0103 cu competitori care impun pre\u0163uri mai mici.<\/p>\n
\nOferta de a pl\u0103ti 280 de dolari per ac\u0163iune, lansat\u0103 \u00een urma discu\u0163iilor cu directorii executivi, a fost unanim acceptat\u0103 de membri ambelor comisii directoriale.<\/p>\n
\nActelion \u00ee\u015fi va concentra unit\u0103\u0163ile de cercetare \u015fi dezvoltare \u00eentr-o companie independent\u0103, cu sediul \u00een Elve\u0163ia, sub numele de R&D NewCo, care va fi condus\u0103 de Jean-Paul Clozel.<\/p>\n
\nJ&J va de\u0163ine, ini\u0163ial, o participa\u0163ie de 16% \u00een R&D NewCo \u015fi va avea dreptul la o cot\u0103 adi\u0163ional\u0103 de 16%.<\/p>\n
\nTranzac\u0163ia este a\u015fteptat\u0103 s\u0103 fie finalizat\u0103 la finalul celui de-al doilea trimsetru.<\/p>\n
\nAc\u0163iunile Actelion au crescut cu 20,3%, ajung\u00e2nd la 273,60 de franci elve\u0163ieni.<\/p>\n","protected":false},"excerpt":{"rendered":"
Compania american\u0103 Johnson & Johnson (J&J) a anun\u0163at, joi, c\u0103 va cump\u0103ra firma elve\u0163ian\u0103 de biotehnologie Actelion pentru 30 de miliarde de dolari, potrivit site-ului agen\u0163iei de pres\u0103 Reuters. Achizi\u0163ia \u00eei va permite companiei J&J acces la portofoliul de medicamentele pentru boli rare al grupului elve\u0163ian, ceea ce va diversifica oferta de medicamente a firmei […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[238,170,9646,10888,21816,16199,13292,272,32949,534,470,473,323,161,8122],"class_list":["post-142575","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-acces","tag-achizitie","tag-agentie","tag-americana","tag-americane","tag-anunt","tag-boli","tag-companie","tag-confrunta","tag-context","tag-cumparare","tag-firma","tag-medicamente","tag-miliarde","tag-oferta"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/142575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=142575"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/142575\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=142575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=142575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=142575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}